SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-102136
Filing Date
2023-04-14
Accepted
2023-04-14 16:25:52
Documents
8
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d430897ddef14a.htm DEF 14A 266797
2 GRAPHIC g430897g24g01.jpg GRAPHIC 64407
3 GRAPHIC g430897g34l67.jpg GRAPHIC 75450
4 GRAPHIC g430897g89r47.jpg GRAPHIC 32910
5 GRAPHIC g430897snap1.jpg GRAPHIC 1121
6 GRAPHIC g430897snap2.jpg GRAPHIC 1525
7 GRAPHIC g430897snap3.jpg GRAPHIC 1216
8 GRAPHIC g430897xx.jpg GRAPHIC 2378
  Complete submission text file 0001193125-23-102136.txt   511042
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 23821490
SIC: 2834 Pharmaceutical Preparations